Association of angiotensin receptor blockers with incident Parkinson's disease in patients with hypertension: A retrospective cohort study
Parkinson's disease (Parkinson's disease) is the second most common neurodegenerative disease after Alzheimer's disease,1 and is mainly characterized by progressive motor symptoms, including resting tremors, bradykinesia, rigidity, and postural dysreflexes. Its main pathological hallmark is a selective loss of dopaminergic neurons in the substantia nigra pars compacta, resulting in dopamine depletion in the striatum. Despite a variety of symptom-alleviating medications for Parkinson's disease, disease modification treatments are not yet available.
Source: The American Journal of Medicine - Category: General Medicine Authors: Hsiu-Chen Lin, Yuan-Fu Tseng, Ai-Ling Shen, Jane Chen-Jui Chao, Chien-Yeh Hsu, Hsiu-Li Lin Source Type: research
More News: Alzheimer's | Brain | General Medicine | Hypertension | Neurology | Parkinson's Disease | Study